{
    "Case ID": "097174",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute"
    ],
    "Legal_Issue": [
        "Whether Teva's counterclaim for indirect patent infringement discloses a reasonable cause of action"
    ],
    "Governing_Law": [
        "Patent Act (Canada)"
    ],
    "Procedural_Stage": [
        "Motion to strike"
    ],
    "Evidence_Assessment": [
        "Allegations that Zambon Companies sold gabapentin, leading to importation by Apotex/Torpharm into Canada"
    ],
    "Decision_Outcome": [
        "Counterclaim not struck; allowed to proceed"
    ],
    "Burden_of_Proof": [
        "On the party moving to strike to show no reasonable cause of action"
    ],
    "Credibility_Factor": [
        "Plausibility of allegations at the pleading stage"
    ],
    "Legal_Rule": [
        "A claim should not be struck unless it is plain and obvious that it discloses no reasonable cause of action"
    ],
    "Standard_of_Review": [
        "De novo"
    ],
    "Procedural_Issue": [
        "Motion to strike for failure to disclose a cause of action"
    ],
    "Grounds_for_Claim": [
        "Indirect (inducement) patent infringement"
    ],
    "Outcome_on_Merits": [
        "Not decided; claim allowed to proceed"
    ],
    "Decision_Maker": [
        "Justice Phelan"
    ],
    "Judicial_Review_Outcome": [
        "Upheld Prothonotary's decision"
    ],
    "Review_Standard": [
        "De novo review"
    ],
    "Procedural_Fairness_Assessment": [
        "Proper procedural posture for motion to strike"
    ],
    "Key_Evidence_Considered": [
        "Alleged sale of gabapentin by Zambon leading to Canadian importation"
    ],
    "Legal_Framework": [
        "Canadian patent law on indirect infringement"
    ],
    "Applicant_Challenge": [
        "Zambon Companies sought to strike Teva's counterclaim"
    ],
    "Court_Result": [
        "Motion to strike dismissed"
    ],
    "Legal_Rule_Source": [
        "Common law and Patent Act"
    ],
    "Standard_of_Proof": [
        "Plain and obvious test"
    ],
    "Defendant_Response": [
        "Motion to strike filed"
    ],
    "Evidence_Type": [
        "Pleading allegations"
    ],
    "Remedy_Requested": [
        "Striking of Teva's counterclaim"
    ],
    "Outcome": [
        "Counterclaim proceeds"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Dismissal of counterclaim"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on motion to strike"
    ],
    "Legal_Provision": [
        "Section 55(1) of the Patent Act"
    ],
    "Authority": [
        "Justice Phelan"
    ],
    "Claimant_Status": [
        "Teva as counterclaimant"
    ],
    "Legal_Provision_Cited": [
        "Patent Act, s 55(1)"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Failure to disclose reasonable cause of action"
    ],
    "Applicable_Process": [
        "Motion practice under Federal Courts Rules"
    ],
    "Outcome_of_Review": [
        "Appeal dismissed; original decision upheld"
    ],
    "Pending_Relief_or_Application": [
        "Motion to strike"
    ],
    "Jurisdiction": [
        "Federal Court of Canada"
    ],
    "Governing_Rule": [
        "Rule 213(3) of the Federal Courts Rules (motion to strike)"
    ]
}